Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis.
Zhao
Wei
W
Xue
Rong
R
Zhou
Zhen-Xian
ZX
Kong
Wei-Jia
WJ
Jiang
Jian-Dong
JD
D000328:Adult; D001599:Berberine / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D008055:Lipids / Q000097:blood*; D008103:Liver Cirrhosis / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008875:Middle Aged
D000960:Hypolipidemic Agents; D008055:Lipids; D001599:Berberine